: 目的: 探讨急性心肌梗死(AMI) 大鼠中缓激肽B1 (BDKB1R) 的表达及依那普利氯沙坦药物治疗
对其的影响. 方法: 结扎大鼠左冠状动脉前降支制备心肌梗死模型. 将60 只大鼠随机分为假手术组…

… The tissue kallikrein-kinin system protects against cardiovascular and renal diseases and
ischemic stroke independently of blood pressure reduction[J]. Biol Chem, 2006, 387(6):1437-…

… -kinin system that … , kinin receptor knockout, kinin receptor analogs, kallikrein analogs, and
kallikrein transgenic methods play an essential role in the treatment of cardiovascular disease …

… : Cardiovascular implants have been widely used as a treatment for various cardiovascular
diseases. … In this review, we focus on the anticoagulant coatings on different cardiovascular …

… diseases, such as cardiovascular diseases (Rawal et al., 2017; Milan et al., 2018), kidney
diseases (… An important component of the kallikrein-kinin system is tissue kallikrein, a serine …

… New progress in the application research of sacubitril and valsartan in cardiovascular
diseases[J]. Qinghai Medical Journal ( 青海医药杂志), 2023, 53(1): 61-64. [24] PRZEZAK A, …

… diseases. This review systematically describes the association between the dysbiosis of gut
microbiota and specific cardiovascular diseases, … found in these diseases and the possible …

… ⁃ angiotensin system in premature coronary artery disease in women:a new insight into
sex⁃related differences in the pathogenesis of the disease[J].Biomolecules,2021,11(7):1036 …

… recombinant adenovirus infection, the cardiac I/R rat model was established by ligation of
left anterior descending coronary artery and reperfusion. The cardiac infarction area and the …